NO853782L - Fremgangsm¨te for fremstilling av terapeutisk aktive furo- pyridinderivater. - Google Patents
Fremgangsm¨te for fremstilling av terapeutisk aktive furo- pyridinderivater.Info
- Publication number
- NO853782L NO853782L NO853782A NO853782A NO853782L NO 853782 L NO853782 L NO 853782L NO 853782 A NO853782 A NO 853782A NO 853782 A NO853782 A NO 853782A NO 853782 L NO853782 L NO 853782L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- group
- hydrogen
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
- Mushroom Cultivation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8414842A FR2570701B1 (fr) | 1984-09-27 | 1984-09-27 | Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO853782L true NO853782L (no) | 1986-04-01 |
| NO162821B NO162821B (no) | 1989-11-13 |
| NO162821C NO162821C (no) | 1990-02-21 |
Family
ID=9308136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO853782A NO162821C (no) | 1984-09-27 | 1985-09-26 | Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4661498A (no) |
| EP (1) | EP0178201B1 (no) |
| JP (1) | JPS61106577A (no) |
| KR (1) | KR860002508A (no) |
| AT (1) | ATE40554T1 (no) |
| AU (1) | AU573390B2 (no) |
| CA (1) | CA1291994C (no) |
| DE (1) | DE3568045D1 (no) |
| DK (1) | DK158953C (no) |
| ES (1) | ES8605522A1 (no) |
| FI (1) | FI82054C (no) |
| FR (1) | FR2570701B1 (no) |
| GR (1) | GR852356B (no) |
| HU (1) | HU192365B (no) |
| IL (1) | IL76535A0 (no) |
| NO (1) | NO162821C (no) |
| NZ (1) | NZ213620A (no) |
| PT (1) | PT81206B (no) |
| ZA (1) | ZA857457B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2566775B1 (fr) * | 1984-06-27 | 1986-10-31 | Synthelabo | Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique |
| FR2619112B1 (fr) * | 1987-08-07 | 1989-11-17 | Synthelabo | Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique |
| FR2635977B1 (fr) * | 1988-09-07 | 1992-05-15 | Synthelabo | Utilisation de derives de tetrahydro-4,5,6,7 furopyridines pour obtenir des medicaments destines au traitement de l'obesite |
| US5795784A (en) | 1996-09-19 | 1998-08-18 | Abbott Laboratories | Method of performing a process for determining an item of interest in a sample |
| US5856194A (en) | 1996-09-19 | 1999-01-05 | Abbott Laboratories | Method for determination of item of interest in a sample |
| UA52681C2 (uk) * | 1997-04-08 | 2003-01-15 | Янссен Фармацевтика Н.В. | Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі |
| UA70334C2 (en) | 1998-10-06 | 2004-10-15 | Janssen Pharmaceutica N V Jans | BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS |
| CZ294532B6 (cs) * | 1998-12-21 | 2005-01-12 | Janssen Pharmaceutica N. V. | Benzisoxazoly a fenony jako alfa2-antagonisté, způsob jejich přípravy a použití a farmaceutický prostředek |
| CN1147490C (zh) | 1999-01-19 | 2004-04-28 | 神经研究公司 | 呋喃并四吡啶衍生物及其药物组合物和用于治疗神经变形疾病的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2215948B1 (no) * | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma | |
| DD210278A5 (de) * | 1982-03-05 | 1984-06-06 | Boehringer Ingelheim Kg | Verfahren zur herstellung neuer basisch substituierter 4-phenyl-4,5,6,7-tetrahydro-thieno-(2,3-c)pyridine |
-
1984
- 1984-09-27 FR FR8414842A patent/FR2570701B1/fr not_active Expired
-
1985
- 1985-09-06 AT AT85401732T patent/ATE40554T1/de not_active IP Right Cessation
- 1985-09-06 DE DE8585401732T patent/DE3568045D1/de not_active Expired
- 1985-09-06 EP EP85401732A patent/EP0178201B1/fr not_active Expired
- 1985-09-26 HU HU853694A patent/HU192365B/hu not_active IP Right Cessation
- 1985-09-26 ZA ZA857457A patent/ZA857457B/xx unknown
- 1985-09-26 PT PT81206A patent/PT81206B/pt not_active IP Right Cessation
- 1985-09-26 US US06/780,453 patent/US4661498A/en not_active Expired - Fee Related
- 1985-09-26 DK DK435285A patent/DK158953C/da not_active IP Right Cessation
- 1985-09-26 ES ES547315A patent/ES8605522A1/es not_active Expired
- 1985-09-26 KR KR1019850007089A patent/KR860002508A/ko not_active Application Discontinuation
- 1985-09-26 GR GR852356A patent/GR852356B/el unknown
- 1985-09-26 JP JP60214460A patent/JPS61106577A/ja active Pending
- 1985-09-26 NO NO853782A patent/NO162821C/no unknown
- 1985-09-26 FI FI853719A patent/FI82054C/fi not_active IP Right Cessation
- 1985-09-26 CA CA000491635A patent/CA1291994C/en not_active Expired - Fee Related
- 1985-09-26 NZ NZ213620A patent/NZ213620A/en unknown
- 1985-09-27 AU AU47952/85A patent/AU573390B2/en not_active Ceased
- 1985-09-29 IL IL76535A patent/IL76535A0/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GR852356B (no) | 1986-01-28 |
| FI853719L (fi) | 1986-03-28 |
| AU573390B2 (en) | 1988-06-09 |
| ES8605522A1 (es) | 1986-03-16 |
| ZA857457B (en) | 1986-05-28 |
| FI853719A0 (fi) | 1985-09-26 |
| EP0178201B1 (fr) | 1989-02-01 |
| FR2570701B1 (fr) | 1987-05-22 |
| PT81206A (fr) | 1985-10-01 |
| ATE40554T1 (de) | 1989-02-15 |
| NO162821B (no) | 1989-11-13 |
| EP0178201A1 (fr) | 1986-04-16 |
| IL76535A0 (en) | 1986-02-28 |
| DE3568045D1 (en) | 1989-03-09 |
| CA1291994C (en) | 1991-11-12 |
| DK158953B (da) | 1990-08-06 |
| FR2570701A1 (fr) | 1986-03-28 |
| NO162821C (no) | 1990-02-21 |
| US4661498A (en) | 1987-04-28 |
| FI82054C (fi) | 1991-01-10 |
| KR860002508A (ko) | 1986-04-26 |
| ES547315A0 (es) | 1986-03-16 |
| DK158953C (da) | 1991-01-14 |
| HUT38945A (en) | 1986-07-28 |
| HU192365B (en) | 1987-05-28 |
| AU4795285A (en) | 1986-04-10 |
| PT81206B (pt) | 1988-01-22 |
| DK435285D0 (da) | 1985-09-26 |
| FI82054B (fi) | 1990-09-28 |
| JPS61106577A (ja) | 1986-05-24 |
| DK435285A (da) | 1986-03-28 |
| NZ213620A (en) | 1988-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| NO164536C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av cis, endo-2-azabicyklo-(5,3,0)-decan-3-karboksylsyre, samt mellomprodukter for anvendelse ved fremstilling derav. | |
| NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| DK53285D0 (da) | (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme | |
| ES2052015T3 (es) | Un metodo de preparacion de una composicion farmaceutica. | |
| ATE99685T1 (de) | Oxadiazolylalkylpurin-derivate, ihre herstellung und ihre verwendung in pharmazeutischen mitteln. | |
| NO853782L (no) | Fremgangsm¨te for fremstilling av terapeutisk aktive furo- pyridinderivater. | |
| DK132188A (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
| DK527984A (da) | 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika | |
| NO881835L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser. | |
| DK408083A (da) | Isoquinolinderivater, deres fremstilling og anvendelse | |
| NO167286C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater. | |
| DK148288D0 (da) | N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne | |
| NO170580C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater | |
| NO913023D0 (no) | Nye bicykliske aminosubstituerte forbindelsr. | |
| NO169442C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser | |
| DK364386D0 (da) | 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse | |
| ES2004255A6 (es) | Procedimiento de preparar compuestos del tipo de las piracinas y analogos. | |
| DK74594A (da) | Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf |